Mobia Medical Announces Pricing of Initial Public Offering
HealthcareTexasOther
Mobia Medical
May 8, 2026
Otsuka Acquires Transcend for $700M
Announced
HealthcarePlatform
Deal Overview
Otsuka has agreed to acquire Transcend in a deal described as $700M, focused on a PTSD drug platform. The transaction is announced as a platform acquisition in the substance-abuse-treatment and mental-health drug space.
Transcend is the target entity in the deal, and Otsuka is the strategic buyer.
Key Details
- Transaction
- Otsuka acquires Transcend
- Deal Size
- Over $100M
Related Deals
Stryker completes acquisition of Amplitude Vascular Systems - MassDevice
HealthcareAdd-on
Stryker→Amplitude Vascular Systems
May 8, 2026
Odyssey, on second try, snags $279M in an IPO
HealthcareNew YorkOther
Odyssey Therapeutics
May 8, 2026
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
HealthcareMassachusettsOther
Odyssey Therapeutics
May 8, 2026
Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy
HealthcarePlatform
Angelini Pharma→Catalyst Pharmaceuticals
May 7, 2026